MBCT vs HEP in Patients With Late-Life Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Study Design \& Recruitment: Phase III randomized controlled trial (RCT) with 200 patients. Participants with a diagnosis of late-life depression (LLD), excluding dementia and other psychiatric comorbidities, will be recruited at three health networks. LLD patients had no earlier depressive episodes before the age of 65. Interventions: Mindfulness-based Cognitive Therapy (MBCT) or Health Enhancement Program (HEP) for 8-weeks, in addition to TAU. MBCT and HEP will have the same group sizes, meeting frequency, and amount of home practice. HEP is a recognized active control where participants learn about diet and exercise, but not meditation.
Epistemonikos ID: 4a48f13dc6bef03054ecd9db2ee480b31713a596
First added on: May 13, 2024